Chronic Urticaria Or Hives - Pipeline Review, H1 2015

1
Chronic Urticaria Or Hives - Pipeline Review, H1
2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Chronic Urticaria Or
  Hives
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Chronic Urticaria Or
  Hives and enlists all their major and minor
  projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Chronic Urticaria Or Hives
  products under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Chronic Urticaria Or Hives
  pipeline on the basis of target, MoA, route of
  administration and molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/chronic
  -urticaria-or-hives-pipeline-review-h1-2015-market
  

3


Table of Content
Table of Contents 2List of Tables 5List of
Figures 5Introduction 6Global Markets Direct
Report Coverage 6Chronic Urticaria Or Hives
Overview 7Therapeutics Development 8Pipeline
Products for Chronic Urticaria Or Hives -
Overview 8Pipeline Products for Chronic
Urticaria Or Hives - Comparative Analysis
9Chronic Urticaria Or Hives - Therapeutics under
Development by Companies 10Chronic Urticaria Or
Hives - Pipeline Products Glance 11Late Stage
Products 11Clinical Stage Products 12Early
Stage Products 13Chronic Urticaria Or Hives -
Products under Development by Companies
14Chronic Urticaria Or Hives - Companies
Involved in Therapeutics Development
15AstraZeneca PLC 15Biofrontera AG
16Bristol-Myers Squibb Company 17ELORAC, Inc.
18
4


Report Overview

• Reasons to buy
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding
  the focus areas of leading companies
• Identify and understand important and diverse
  types of therapeutics under development for
  Chronic Urticaria Or Hives
• Plan mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline
• Devise corrective measures for pipeline projects
  by understanding Chronic Urticaria Or Hives
  pipeline depth and focus of Indication
  therapeutics
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies
• Enquire At http//www.researchbeam.com/chronic-u
  rticaria-or-hives-pipeline-review-h1-2015-market/e
  nquire-about-report

5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/chronic-urticaria-or-h
ives-pipeline-review-h1-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com